BeyondSpring Inc. Deferred Tax Assets, Operating Loss Carryforwards
BeyondSpring Inc. (BYSI) had Deferred Tax Assets, Operating Loss Carryforwards of $29.68 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.68M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.18M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.32M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.57M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $29.68M 10-K · filed 2026-03-25 |
| 2024-12-31 | $28.18M 10-K · filed 2026-03-25 |
| 2023-12-31 | $28.32M 10-K · filed 2025-03-27 |
| 2022-12-31 | $26.57M 20-F · filed 2023-04-18 |
| 2021-12-31 | $24.21M 20-F · filed 2023-04-18 |
| 2020-12-31 | $18.03M 20-F · filed 2022-04-14 |
| 2019-12-31 | $14.35M 20-F · filed 2021-04-30 |
| 2018-12-31 | $13.40M 20-F · filed 2020-04-30 |
| 2017-12-31 | $7.24M 20-F · filed 2019-04-30 |
| 2016-12-31 | $8.32M 20-F · filed 2018-04-03 |
| 2015-12-31 | $3.81M 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |